Table 4

Opioid use in patients at baseline and follow-up

OPIOID USEBASELINE* (INITIAL CONSULTATION), N (%)FOLLOW-UP* (3–4 MO AFTER INITIAL CONSULTATION), N (%)P VALUE
All interviewed patients (n = 71)
  • Using prescription opioids31 (44)19 (27).102
  • Using nonprescription opioids9 (13)2 (3).063
  • Methadone therapy3 (4)9 (13).012
Problem opioid users (n = 29)
  • Currently a problem29 (41)11 (15)<.001
  • * Percentages have been rounded.

  • Number of patients reporting any current opioid use whether problematic or not.

  • Statistically significant values (α = 0.05).